Purpose: To describe a case of linezolid toxic optic neuropathy in a 71-year-old female and review the relevant literature.
Observations: An adult female with progressive, symmetric vision loss was hypothesized to have linezolid toxic optic neuropathy. Following cessation of linezolid, the patient experienced improvement in visual function over two months.
Conclusions And Importance: Patients diagnosed with linezolid toxic optic neuropathy can expect some return of visual function after cessation. The degree of return does not correlate to the cumulative dose of the drug. The goal of this study was to summarize and add to the current body of literature on the topic.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480323 | PMC |
| http://dx.doi.org/10.1016/j.ajoc.2023.101922 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Advanced oxidation coupled with LC-HRMS: Elucidating transformation products of linezolid, discovering in wastewaters and conducting in silico toxicity assessments.
J Hazard Mater
December 2024
Laboratory of Environmental Pollution Control, Department of Chemistry, Aristotle University of Thessaloniki, Thessaloniki 541 24, Greece; Center for Interdisciplinary Research and Innovation (CIRI-AUTH), Balkan Center, Thessaloniki 57001, Greece. Electronic address:
Antibiotics are prevalent in wastewater treatment plants and are subsequently released into aquatic environments, threatening aquatic organisms and compromising drinking water quality. Consequently, investigating their environmental fate and developing efficient removal processes is crucial. The degradation and fate of the antibiotic drug linezolid were investigated, focusing on the formation of transformation products (TPs).
View Article and Find Full Text PDFOptimizing the dosing regimens of linezolid against gram-positive cocci in critically ill patients with different renal functions: a Monte Carlo simulation.
J Chemother
December 2024
Department of Pharmacy, the First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
To promote the accurate administration of linezolid, this study aimed to evaluate its dosage regimens in critically ill patients with varying renal functions. This evaluation was based on a combined analysis of pharmacokinetic (PK), pharmacodynamic (PD), and toxicodynamic (TD) indices. The percentage of therapeutic target attainment (PTTA) was used as the index for PK/PD/TD, defined as simultaneously meeting two PK/PD criteria (AUC/MIC ≥ 100 and C between 2.
View Article and Find Full Text PDFTherapeutic Strategies for Tuberculosis: Progress and Lessons Learned.
Biomed Environ Sci
November 2024
Department of Bacteriology and Immunology, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China.
Article Synopsis
- * First-line treatments are being challenged by resistance, leading to the need for more toxic second-line drugs, but new agents and treatment regimens, like the BPaLM protocol, show promise for better efficacy and shorter treatment times.
- * Emerging strategies, including immunotherapy and cell therapies, aim to boost the immune response against TB, but significant obstacles remain in reaching the WHO's goal to end TB, especially due to resource diversion from the COVID-
Vancomycin and linezolid: severe cutaneous adverse reactions to drugs.
Expert Opin Drug Saf
December 2024
Department of Pharmacy, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Background: Severe cutaneous adverse reactions (SCARs), including Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), and Acute Generalized Exanthematous Pustulosis (AGEP), pose significant therapeutic challenges. Vancomycin and linezolid have been linked to these life-threatening conditions, necessitating a better understanding of their associated risks.
Methods: We conducted a retrospective analysis using data from the FDA Adverse Event Reporting System (FAERS) database.
Linezolid induced acute toxic leukoencephalopathy and severe thrombocytopenia presenting as stroke mimic-a case report.
Oxf Med Case Reports
December 2024
Haematology, Colchester Hospital, East Suffolk and North Essex NHS Foundation Trust, Turner Road, Colchester, United Kingdom.
Article Synopsis
- A 67-year-old woman was admitted for right-sided weakness, shaking, lethargy, and loss of appetite after completing treatment for a diabetic foot infection.
- MRI results revealed changes in the deep white matter of her brain, potentially indicating an ischemic stroke, alongside symptoms of verbal dysfluency and visual disturbances.
- After a decline in her condition and a drop in blood counts, she was diagnosed with Linezolid-induced Acute Toxic Leukoencephalopathy and thrombocytopenia based on her clinical presentation and imaging.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!